Efficacy of Fremanezumab Treatment in Reducing Monthly Migraine Days in Patients with Migraine and Major Depressive Disorder: Results from the Unite Study

AuthID
P-00Z-6JT
7
Author(s)
Lipton, R
·
Campos, VR
·
Krasenbaum, L
·
Ning, X
·
Galic, M
·
Marmura, M
Tipo de Documento
Abstract
Year published
2023
Publicado
in HEADACHE, ISSN: 0017-8748
Volume: 63, Páginas: 134-134 (1)
Conference
65Th Annual Meeting of the American-Headache-Society (Ahs), Date: JUN 15-18, 2023, Location: Austin, TX
Indexing
Publication Identifiers
Wos: WOS:001043094900178
Source Identifiers
ISSN: 0017-8748
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.